| MeSH term | MeSH ID | Detail |
|---|---|---|
| Coronary Disease | D003327 | 70 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Mitochondrial Diseases | D028361 | 25 associated lipids |
Total
3
Palmitoylcarnitine
Palmitoylcarnitine is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1026 references associated with Palmitoylcarnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Palmitoylcarnitine
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Palmitoylcarnitine
NCBI Entrez Crosslinks
All references with Palmitoylcarnitine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Zhang XJ et al. | Measurement of precursor enrichment for calculating intramuscular triglyceride fractional synthetic rate. | 2012 | J. Lipid Res. | pmid:21934122 |
| Tonazzi A et al. | Identification by site-directed mutagenesis of a hydrophobic binding site of the mitochondrial carnitine/acylcarnitine carrier involved in the interaction with acyl groups. | 2012 | Biochim. Biophys. Acta | pmid:22365929 |
| Nguyen UT et al. | Small-molecule modulators of Listeria monocytogenes biofilm development. | 2012 | Appl. Environ. Microbiol. | pmid:22194285 |
| Wenderska IB et al. | Palmitoyl-DL-carnitine is a multitarget inhibitor of Pseudomonas aeruginosa biofilm development. | 2011 | Chembiochem | pmid:22045628 |
| Brandhonneur N et al. | Ex vivo and in vivo diffusion of ropivacaine through spinal meninges: influence of absorption enhancers. | 2011 | Int J Pharm | pmid:21056096 |
| Doi N et al. | Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers. | 2011 | Drug Metab. Pharmacokinet. | pmid:21206134 |
| De Jesús VR et al. | Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. | 2010 | Clin. Chim. Acta | pmid:20122909 |
| Hoffman DL and Brookes PS | Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. | 2009 | J. Biol. Chem. | pmid:19366681 |
| Wu Y et al. | The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction. | 2009 | J. Pharmacol. Exp. Ther. | pmid:19403851 |
| Bonnefont JP et al. | Bezafibrate for an inborn mitochondrial beta-oxidation defect. | 2009 | N. Engl. J. Med. | pmid:19228633 |